Rock Springs Capital Management LP Collegium Pharmaceutical, Inc Transaction History

Rock Springs Capital Management LP

$2.94 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.23 - $24.28 $1.87 Million - $2.14 Million	-88,000 Reduced 13.54%	562,000 $12.6 Million
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $1.73 Million - $2.24 Million	-75,000 Reduced 10.34%	650,000 $15.6 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $3.06 Million - $3.74 Million	-175,000 Reduced 19.44%	725,000 $13.5 Million
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $355,000 - $507,800	-20,000 Reduced 2.17%	900,000 $17.8 Million
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $3.47 Million - $4.7 Million	-180,000 Reduced 16.36%	920,000 $21.8 Million
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $1.34 Million - $1.67 Million	-75,000 Reduced 6.38%	1,100,000 $22 Million
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $5.56 Million - $10.2 Million	-400,000 Reduced 25.4%	1,175,000 $19.2 Million
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $30,955 - $64,340	-2,893 Reduced 0.18%	1,575,000 $32.4 Million
Q1 2019 May 15, 2019	SELL	$13.58 - $18.72 $369,538 - $509,408	-27,212 Reduced 1.7%	1,577,893 $23.9 Million
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $665,026 - $885,501	-44,995 Reduced 2.73%	1,605,105 $27.6 Million
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $1,416 - $2,430	100 Added 0.01%	1,650,100 $24.3 Million
Q2 2018 Aug 14, 2018	SELL	$21.79 - $28.29 $5.88 Million - $7.64 Million	-270,000 Reduced 14.06%	1,650,000 $39.4 Million
Q1 2018 May 15, 2018	BUY	$18.15 - $29.21 $622,018 - $1 Million	34,271 Added 1.82%	1,920,000 $49.1 Million
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $750,779 - $1.55 Million	80,729 Added 4.47%	1,885,729 $34.8 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $16.5 Million - $21.6 Million	1,805,000	1,805,000 $18.9 Million

Others Institutions Holding COLL

# of Institutions

254

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$191 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$86.7 Million
1.79% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.59M
Shares

$85.2 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$77.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.66M
Shares

$54.5 Million
0.1% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account